Zusammenfassung
Die Inzidenz des Mammakarzinoms liegt in den westlichen Ländern bei 70–80/100.000 Frauen/Jahr. Der Häufigkeitsgipfel liegt im 5. und 6. Lebensjahrzehnt. Durchschnittlich werden in Deutschland jährlich etwa 45.000 neue Fälle von Brustkrebs diagnostiziert. Die Überlebensraten über alle Stadien betragen nach 10 Jahren etwa 60%. Das Mammakarzinom verursacht etwa 20% aller Krebstodesfälle der Frau.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Azzopardi JG (1979) Problems in breast pathology. Saunders, Philadelphia
Bässler R (1998) Mamma. In: Remmele W (Hrsg) Pathologie, Bd 3. Springer, Berlin Heidelberg New York Tokio, S 305–392
Bäcker W, Moll R, Dervan P et al. (2002) Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol 198 /4: 458–467
Böcker W, Moll R, Poremba C et al. (2002) Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: A new cell biological concept. Lab Invest 82 /6: 737–746
Bäcker W, Schnitt S, Silverstein M (2004) Preneoplasia of the breast. Springer, Berlin Heidelberg New York Tokio (in press)
Bürger H, Otterbach F, Simon R et al. (1999) Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 187 /4: 396–402
Bürger H, Otterbach F, Simon R et al. (1999) Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 189 /4: 521–526
Bürger H, Simon R, Schäfer K-L et al. (2000) Genetic relationship of lobular carcinoma in situ, ductal carcinoma in situ and associated invasive carcinoma of the breast. Mol Pathol 53/3: 1 18–121
Dixon JM, Sainsbury JRC (1998) Handbook of Diseases of the breast. 2nd ed. Churchill Livingstone: Edinburgh
Elston CW, Ellis IO (1998) The breast. Churchill Livingstone, Edinburgh
Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Bäcker W (2000) Cytokeratin 5/6 immunohistochemistry assists the differencial diagnosis of atypical proliferations of the breast. Histopathol 37 /3: 232–240
Page DL, Anderson TJ (1987) Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh
Rosen PP (2001) Rosen’s breast pathology, 2nd edn. Lippincott/ Williams and Wilkins, Philadelphia
Rüschoff J, Emons G, Gebert G, Thomas C (1993) Weibliches Genitale. Grundlagen der klinischen Medizin, Bd 7. Schattauer, Stuttgart
Sloane I (2001) Quality assurance guidelines for pathology in mammography following. Non-operative diagnosis. p. 159–171 and Open biopsy and resection specimens. In: European guidelines for quality assurance in mammography screening.Third Edition. EUREF p173–212
Silverstein MJ (ed) (2002) Ductal carcinoma in situ of the breast. Lippincott/Williams and Wilkins, Philadelphia
Sloane RI (2001) Biopsy pathology of the breast, 2nd edn. Arnold, London
Tavassoli FA (1999) Pathology of the breast, 2nd edn. Appleton and Lange, Norwalk
Tavassoli FA, Devilee P (2003) WHO Classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Böcker, W. (2004). Pathologie der Mamma. In: Duda, V.F., Schulz-Wendtland, R. (eds) Mammadiagnostik. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08458-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-08458-8_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-08459-5
Online ISBN: 978-3-662-08458-8
eBook Packages: Springer Book Archive